Brian R. Ott

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

Yasser Iturria‐Medina, Roberto C. Sotero, P.-J. Toussaint et al. · Nature Communications · 2016 · 1.2K citations · Full text

Life Sciences, Neurology, Neuroscience +17

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

Robert P. Giugliano, Terje R. Pedersen, Jeong-Gun Park et al. · The Lancet · 2017 · 677 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

Alexandra L. Young, Razvan Marinescu, Neil P. Oxtoby et al. · Nature Communications · 2018 · 586 citations · Full text

Medicine, Neurology, Neuroscience +17

Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease

Jacob W. Vogel, Yasser Iturria‐Medina, Olof Strandberg et al. · Nature Communications · 2020 · 541 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Cognitive Function in a Randomized Trial of Evolocumab

Robert P. Giugliano, François Mach, Kenton H. Zavitz et al. · New England Journal of Medicine · 2017 · 482 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16